| Microorganism |
|
|
|
| Antimicrobial |
 |
|
Reference |
| Staphylococcus epidermidis (methicillin-susceptible) |
0.063 |
0.125 |
0.063 － 0.125 |
Meropenem (Merrem) |
115 |
| Staphylococcus epidermidis (methicillin-susceptible) |
0.063 |
0.125 |
≤0.063 － 1 |
L-036 |
56 |
| Staphylococcus epidermidis (methicillin-susceptible) |
0.063 |
0.5 |
0.032 － 4 |
Cefdinir (Omnicef, Cefdiel) |
600 |
| Staphylococcus epidermidis (methicillin-susceptible) |
0.063 |
0.5 |
0.032 － 8 |
R-95867 |
600 |
| Staphylococcus epidermidis (methicillin-susceptible) |
<0.12 |
<0.12 |
<0.12 － ? |
Quinupristin/Dalfopristin (Synercid) |
1060 |
| Staphylococcus epidermidis (methicillin-susceptible) |
0.12 |
0.25 |
0.06 － 0.25 |
Amoxicillin-clavulanate |
186 |
| Staphylococcus epidermidis (methicillin-susceptible) |
0.12 |
0.25 |
≤0.12 － 0.5 |
Quinupristin/Dalfopristin (Synercid) |
186 |
| Staphylococcus epidermidis (methicillin-susceptible) |
0.12 |
1 |
0.06 － 4 |
Moxifloxacin (BAY 12-8039, Avelox) |
102 |
| Staphylococcus epidermidis (methicillin-susceptible) |
0.12 |
2 |
0.03 － 8 |
Garenoxacin (T-3811, BMS-284756) |
102 |
| Staphylococcus epidermidis (methicillin-susceptible) |
0.12 |
2 |
0.06 － 4 |
Gatifloxacin (Tequin) |
12 |
| Staphylococcus epidermidis (methicillin-susceptible) |
0.12 |
4 |
0.12 － 16 |
Levofloxacin (Levaquin, Quixin) |
12 |
| Staphylococcus epidermidis (methicillin-susceptible) |
0.125 |
0.125 |
0.063 － 0.125 |
Meropenem (Merrem) |
952 |
| Staphylococcus epidermidis (methicillin-susceptible) |
0.125 |
0.25 |
0.125 － 0.25 |
Oxacillin (Prostaphilin, Bactocil, Prostaphlin) |
115 |
| Staphylococcus epidermidis (methicillin-susceptible) |
0.125 |
0.5 |
≥0.063 － 0.5 |
Faropenem |
56 |
| Staphylococcus epidermidis (methicillin-susceptible) |
0.125 |
1 |
≤0.063 － 2 |
Cefdinir (Omnicef, Cefdiel) |
56 |
| Staphylococcus epidermidis (methicillin-susceptible) |
0.13 |
0.5 |
0.03 － 2 |
Quinupristin/Dalfopristin (Synercid) |
7 |
| Staphylococcus epidermidis (methicillin-susceptible) |
0.13 |
0.5 |
0.06 － 1 |
Daptomycin (Cubicin) |
7 |
| Staphylococcus epidermidis (methicillin-susceptible) |
0.2 |
0.78 |
0.1 － 3.13 |
Levofloxacin (Levaquin, Quixin) |
17 |
| Staphylococcus epidermidis (methicillin-susceptible) |
0.2 |
1.56 |
0.05 － 6.25 |
Ciprofloxacin (Cipro, Ciproxin, Ciprobay) |
17 |
| Staphylococcus epidermidis (methicillin-susceptible) |
0.25 |
0.5 |
0.12 － 0.5 |
Sparfloxacin (AT-4140, Zagam) |
374 |
| Staphylococcus epidermidis (methicillin-susceptible) |
0.25 |
0.5 |
0.125 － 0.5 |
Ciprofloxacin (Cipro, Ciproxin, Ciprobay) |
248 |
| Staphylococcus epidermidis (methicillin-susceptible) |
0.25 |
1 |
≤0.25 － 16 |
Ampicillin (Omnipen) |
186 |
| Staphylococcus epidermidis (methicillin-susceptible) |
0.25 |
2 |
0.063 － 4 |
Cefditoren (Spectracef) |
600 |
| Staphylococcus epidermidis (methicillin-susceptible) |
0.25 |
4 |
0.03 － 4 |
Amoxicillin-clavulanic acid (Augmentin) |
102 |
| Staphylococcus epidermidis (methicillin-susceptible) |
0.25 |
4 |
0.06 － 4 |
Gatifloxacin (Tequin) |
102 |
| Staphylococcus epidermidis (methicillin-susceptible) |
0.25 |
4 |
0.125 － 8 |
Levofloxacin (Levaquin, Quixin) |
56 |
| Staphylococcus epidermidis (methicillin-susceptible) |
0.25 |
8 |
0.063 － 128 |
Ofloxacin (Floxin) |
600 |
| Staphylococcus epidermidis (methicillin-susceptible) |
0.25 |
16 |
0.015 － 8 |
Ciprofloxacin (Cipro, Ciproxin, Ciprobay) |
12 |